Catalyst
Slingshot members are tracking this event:
Gelesis (PTCHF) Enrolls First Patient in Pivotal Trial GLOW Evaluating Gelesis100 in Weight Loss in Overweight and Obese Adults, Including Those with Prediabetes and Type 2 Diabetes
- Source Link:
- http://www.gelesis.com/press-releases/04262016.php
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 26, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
First Patient Enrollment, Pivotal Trial, Glow, Gelesis100, Weight Loss, Overweight, Obese, Adults, Type 2 Diabetes, Prediabetes
